Robert Willette

Dr. Robert Willette is an eminent discovery pharmacologist, a pharmaceutical industry veteran and a cardiovascular and metabolic disorders expert. He is the founder and president of POC Pharma Consulting, offering strategic advice to discovery and development companies.

Previously, Dr. Willette spent over thirty years in the pharmaceutical industry, most recently serving as the Vice President, Head and Senior Fellow of GSK’s Heart Failure & Renal Discovery Performance Unit. During his industry tenure he has led and advanced multiple internal discovery programs and alliances across therapeutic modalities. He is the recipient of American Heart Association’s Robert Seikert award for outstanding contribution to stroke research and the George Koelle award for contributions in Pharmacology. Dr. Willette has authored >150 original peer reviewed research papers and his other notable accomplishments include President of the Mid-Atlantic Pharmacology Society, adjunct professorship at Thomas Jefferson University, scientific advisor to the Nephcure Foundation and he currently serves as an industry mentor at the University of Pennsylvania, interim CSO at Complexa Therapeutic, Inc. and consulting CSO at ImmunoMet, Inc.

Dr. Willette received his doctoral degree from the Department of Pharmacology at Rutgers University, School of Medicine and Dentistry in New Jersey and pursued his postdoctoral training in cardiopulmonary biology at the Veterans Administration in NJ and Department of Neurosurgery at Rutgers University and in neurobiology at the Weill Medical College, Cornell University.